NEULANDLAB / NSE / Major Drugs
Neuland Laboratories
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High19,748.4
Target Low11,416
Target Mean1.5
Target Median62.5
Risk Metrics
Overall RiskBalanced risk
Board Risk40.44
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Neuland Laboratories fixes July 24 record date for dividend scanx.trade
Neuland Laboratories Ltd is Rated Sell Markets Mojo
Neuland Laboratories to hold non-deal roadshow on June 11 scanx.trade
Neuland Laboratories Ltd Upgraded to Hold as Technicals Improve Despite Financial Challenges Markets Mojo
Neuland Laboratories Upgraded to Buy on Strong Financials and Bullish Technicals Markets Mojo
Neuland Laboratories management to attend Nuvama UK Conference scanx.trade
Neuland Laboratories Ltd: Technical Momentum Shifts Signal Mildly Bullish Outlook Markets Mojo
Neuland Laboratories Ltd Shows Strong Technical Momentum Amid Bullish Shift Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

